PHCbi unveils cell growth system for analysis use
The Biomedical Division (PHCbi) of PHC Company has launched the LiCellGrow cell growth system, designed for analysis functions in Japan and sure different international locations worldwide.
LiCellGrow helps high quality manufacturing of cell and gene therapies and permits builders to mechanically monitor tradition circumstances and visualize metabolic adjustments in cells in actual time.
Uncover B2B advertising that delivers
Mix enterprise intelligence and editorial excellence to succeed in engaged professionals throughout 36 main media platforms.
Extra info
It was developed by PHCbi to help remedy builders in figuring out optimum tradition circumstances throughout course of growth.
The system integrates In-Line monitoring know-how that repeatedly measures glucose and lactate concentrations, that are notable key indicators of cell metabolism.
The management know-how makes use of these measurements to regulate the cell tradition medium at optimum time factors. This method is predicated on PHCbi’s electrochemical measurement platform, developed over greater than thirty years of innovation within the discipline of blood glucose sensors.
LiCellGrow screens metabolic information in actual time and adjusts medium alternate accordingly. This course of helps constant product high quality and aligns with the High quality by Design rules for scientifically sturdy manufacturing processes.
The system’s single-use design makes use of particular tradition luggage and might be positioned in commonplace CO₂ incubators with out particular facility necessities.
LiCellGrow builds on the in-line monitoring know-how launched in LiCellMo, a reside cell metabolic analyzer launched for analysis use.
PHCbi plans to broaden its providing from late 2026 to early 2028, together with develop luggage with filtration capabilities, dissolved oxygen meter items and cGMP-compliant consumables.
Chikara Takauo, President of PHC Company and Head of PHCbi, mentioned: “We’re excited to launch LiCellGrow and supply remedy builders with a brand new approach to resolve frequent challenges in high quality, value and supply of cell and gene therapies.
“Constructing on the success of our LiCellMo analysis system, LiCellGrow represents a major step ahead in making CBT manufacturing environment friendly, dependable and scalable. We’re dedicated to increasing our PHCbi providing to proceed to drive the adoption of CBT and different superior remedy choices for difficult-to-treat circumstances.”
